Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexian Wei

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Environmental Toxicology|July 8, 2023
MiR-494-3p aggravates pirarubicin-induced cardiomyocyte injury by regulating MDM4/p53 signaling pathwayPeng Huang, Yibing Zhang, Fengjun Wang, et al.
Cancer Gene Therapy|April 27, 2022
Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysisJiulong Ma, Chen Chen, Shan Liu, et al.
International Journal of Biological Macromolecules|June 11, 2023
CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axisJiulong Ma, Chen Chen, Zhimin Fan, et al.
Complementary Therapies in Medicine|September 21, 2020
The influence of maternal vitamin D supplementation on infant vitamin D status: A systematic review and meta-analysesXiaojing Zhong, Ying Xiong, Dexian Wei, et al.
Molecular Immunology|March 1, 2025
circSTIL mediates pirarubicin inhibiting the malignant phenotype of triple-negative breast cancer and acts as a biomarker in plasma exosomesJiahua Ji, Min Li, Kaixu Yan, et al.
Vaccines|July 30, 2025
Research and Clinical Progress of Therapeutic Tumor VaccinesChunyan Dong, Zhuang Li, Dejiang Tan, et al.
Biochemical Pharmacology|December 22, 2024
CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p/TFDP2 axisDexian Wei, Fan Zhang, Min Li, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Environmental Toxicology|July 8, 2023
MiR-494-3p aggravates pirarubicin-induced cardiomyocyte injury by regulating MDM4/p53 signaling pathwayPeng Huang, Yibing Zhang, Fengjun Wang, et al.
Cancer Gene Therapy|April 27, 2022
Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysisJiulong Ma, Chen Chen, Shan Liu, et al.
International Journal of Biological Macromolecules|June 11, 2023
CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axisJiulong Ma, Chen Chen, Zhimin Fan, et al.
Complementary Therapies in Medicine|September 21, 2020
The influence of maternal vitamin D supplementation on infant vitamin D status: A systematic review and meta-analysesXiaojing Zhong, Ying Xiong, Dexian Wei, et al.
Molecular Immunology|March 1, 2025
circSTIL mediates pirarubicin inhibiting the malignant phenotype of triple-negative breast cancer and acts as a biomarker in plasma exosomesJiahua Ji, Min Li, Kaixu Yan, et al.
Vaccines|July 30, 2025
Research and Clinical Progress of Therapeutic Tumor VaccinesChunyan Dong, Zhuang Li, Dejiang Tan, et al.
Biochemical Pharmacology|December 22, 2024
CircDUSP16 mediates the effect of triple-negative breast cancer in pirarubicin via the miR-1224-3p/TFDP2 axisDexian Wei, Fan Zhang, Min Li, et al.
Pageof 2